Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,003,213
-
Total 13F shares
-
119,592
-
Share change
-
+34,982
-
Total reported value
-
$102,817
-
Price per share
-
$0.86
-
Number of holders
-
12
-
Value change
-
+$30,259
-
Number of buys
-
9
-
Number of sells
-
2
Institutional Holders of PALISADE BIO, INC. - Common Stock (PALI) as of Q3 2025
As of 30 Sep 2025,
PALISADE BIO, INC. - Common Stock (PALI) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,592 shares.
The largest 10 holders included
TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, XTX Topco Ltd, Newbridge Financial Services Group, Inc., MORGAN STANLEY, Tower Research Capital LLC (TRC), CITIGROUP INC, Rockefeller Capital Management L.P., and Federation des caisses Desjardins du Quebec.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.